Next Steps Unclear For Impax Following “Not Approvable” Letter On Vadova For Parkinson’s
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA is concerned that the name Vadova may cause medication errors caused by confusing the drug with other marketed forms of carbidopa/levodopa.